2m 2m 2m 2m 2m 2m 2m
SOPHIA GENETICS N (SOPH)
NASDAQ
$4.79+$0.005 (+0.10%)
Price as of Jun 03, 2026 7:23 PM EDT- $451.1MMarket Cap
- 63.31%1-Year Change
- Health Information ServicesIndustry
SOPHIA GENETICS N (SOPH)
$4.79+$0.005 (+0.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 77.3M +18.56% | 65.2M +4.49% | 62.4M +31.14% | 47.6M +17.58% | |
Cost of Revenue | 25.2M +18.64% | 21.2M +9.14% | 19.5M +19.33% | 16.3M +7.07% | |
Gross Profit | 52.1M +18.53% | 43.9M +2.39% | 42.9M +37.30% | 31.3M +23.92% | |
Sales and Marketing Expense | 36.1M +22.98% | 29.4M +3.33% | 28.4M +0.55% | 28.3M -1.63% | |
Research and Development Expense | -34.2M -0.44% | -34.4M -7.04% | -37.0M +4.52% | -35.4M +33.08% | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 52.6M +11.95% | 47.0M -11.91% | 53.3M -4.51% | 55.8M +34.48% | |
Operating Profit | -70.9M +6.52% | -66.6M -11.04% | -74.8M -14.80% | -87.8M N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -4.6M +138.06% | -1.9M +225.34% | -588,000 -7.98% | -639,000 -2.89% | |
Interest Income and Expense and Net | -4.6M +138.06% | -1.9M +225.34% | -588,000 -7.98% | -639,000 -2.89% | |
Total Nonoperating Income and Expense | 4.6M +138.06% | 1.9M +225.34% | 588,000 -7.98% | 639,000 -2.89% | |
Income before Taxes | -79.0M +26.41% | -62.5M -20.88% | -79.0M -9.68% | -87.4M +18.70% | |
Income Taxes | 1.5M +23.63% | 1.2M +151.65% | 486,000 +457.35% | -136,000 -180.95% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -79.0M +26.41% | -62.5M -20.88% | -79.0M -9.68% | -87.4M +18.70% | |
Net Income from Continuing Operations Applicable to Common | -79.0M +26.41% | -62.5M -20.88% | -79.0M -9.68% | -87.4M +18.70% | |
Basic EPS and Net Income | -1.17 +23.16% | -0.95 -22.13% | -1.22 -10.29% | -1.36 N/A | |
Diluted EPS and Net Income | -1.17 +23.16% | -0.95 -22.13% | -1.22 -10.29% | -1.36 N/A | |
Basic Weighted Average Shares | 67.5M +2.24% | 66.1M +2.03% | 64.8M +1.02% | 64.1M N/A | |
Diluted Weighted Average Shares | 67.5M +2.24% | 66.1M +2.03% | 64.8M +1.02% | 64.1M N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 70.3M -12.39% | 80.2M -34.91% | 123.3M -23.59% | 161.3M -16.41% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 70.3M -12.39% | 80.2M -34.91% | 123.3M -23.59% | 161.3M -16.41% | |
Total Current Assets | 99.1M -0.33% | 99.4M -32.86% | 148.0M -24.56% | 196.3M -30.62% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 5.7M +8.75% | 5.2M -30.26% | 7.5M +4.77% | 7.1M +52.88% | |
Total Long-Term Assets | 64.0M +14.40% | 55.9M -3.79% | 58.1M +22.12% | 47.6M +27.51% | |
Total Assets | 163.0M +4.97% | 155.3M -24.66% | 206.2M -15.45% | 243.8M -23.84% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 50.5M +88.52% | 26.8M -24.76% | 35.6M +32.86% | 26.8M -6.27% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 65.4M +104.14% | 32.0M +67.68% | 19.1M +12.99% | 16.9M +4.50% | |
Total Liabilities | 115.9M +97.02% | 58.8M +7.50% | 54.7M +25.18% | 43.7M -2.38% | |
Retained Earnings | -519.3M +17.94% | -440.3M +16.54% | -377.8M +26.43% | -298.8M +41.38% | |
Total Stockholders Equity | 47.1M -51.14% | 96.5M -36.29% | 151.4M -24.33% | 200.1M -27.33% | |
Total Shares Outstanding | 68.5M +2.70% | 66.7M +2.23% | 65.2M +1.56% | 64.2M +0.59% | |
Cash Flow | |||||
Cash from Operating Activities | -35.9M -16.18% | -42.8M -11.84% | -48.6M -30.70% | -70.1M +20.98% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -8.7M +6.04% | -8.2M -198.27% | 8.3M -80.18% | 42.0M +173.72% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 30.2M +160.48% | 11.6M +511.25% | -2.8M +79.66% | -1.6M -100.66% | |
Financials Ratio | |||||
Gross Margin | 67.40% -0.03% | 67.42% -2.02% | 68.80% +4.70% | 65.71% N/A | |
Operating Margin | -91.76% -10.16% | -102.14% -14.86% | -119.97% -35.03% | -184.66% N/A | |
Return on Assets | -49.63% +43.54% | -34.58% -1.50% | -35.10% +13.20% | -31.01% N/A | |
Return on Equity | -110.00% +118.20% | -50.41% +12.20% | -44.93% +22.16% | -36.78% N/A | |
Revenue Growth | 18.56% +313.20% | 4.49% -85.57% | 31.14% +77.17% | 17.58% N/A | |
Current Ratio | 1.96 -47.13% | 3.71 -10.77% | 4.16 -43.22% | 7.32 N/A | |
Cash Ratio | 1.39 -53.52% | 2.99 -13.49% | 3.46 -42.49% | 6.02 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow